BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spica D, Junker T, Dickenmann M, Schaub S, Steiger J, Rüfli T, Halter J, Hopfer H, Holbro A, Hirt-Minkowski P. Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation. Case Rep Nephrol Dial 2019;9:149-57. [PMID: 31828078 DOI: 10.1159/000503951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Salvadori M, Tsalouchos A. Innovative immunosuppression in kidney transplantation: A challenge for unmet needs. World J Transplant 2022; 12(3): 27-41 [DOI: 10.5500/wjt.v12.i3.27] [Reference Citation Analysis]
2 Mujtahedi SS, Yigitbilek F, Ozdogan E, Schinstock CA, Stegall MD. Antibody-Mediated Rejection: the Role of Plasma Cells and Memory B Cells. Curr Transpl Rep 2021;8:272-80. [DOI: 10.1007/s40472-021-00342-1] [Reference Citation Analysis]
3 Yang J, Liu X. Immunotherapy for Refractory Autoimmune Encephalitis. Front Immunol 2021;12:790962. [PMID: 34975890 DOI: 10.3389/fimmu.2021.790962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rodriguez-Ramirez S, Al Jurdi A, Konvalinka A, Riella LV. Antibody-mediated rejection: prevention, monitoring and treatment dilemmas. Curr Opin Organ Transplant 2022. [PMID: 35950887 DOI: 10.1097/MOT.0000000000001011] [Reference Citation Analysis]
5 Mayer KA, Budde K, Halloran PF, Doberer K, Rostaing L, Eskandary F, Christamentl A, Wahrmann M, Regele H, Schranz S, Ely S, Firbas C, Schörgenhofer C, Kainz A, Loupy A, Härtle S, Boxhammer R, Jilma B, Böhmig GA. Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial. Trials 2022;23:270. [PMID: 35395951 DOI: 10.1186/s13063-022-06198-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Mayer KA, Budde K, Jilma B, Doberer K, Böhmig GA. Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials. Expert Opin Emerg Drugs 2022;:1-17. [PMID: 35715978 DOI: 10.1080/14728214.2022.2091131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Spasovski G, Trajceska L, Rambabova-Bushljetik I. Pharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to date. Expert Opin Pharmacother 2022. [PMID: 35835450 DOI: 10.1080/14656566.2022.2102418] [Reference Citation Analysis]
8 Markmann C, Bhoj VG. On the road to eliminating long-lived plasma cells-"are we there yet?". Immunol Rev 2021;303:154-67. [PMID: 34351644 DOI: 10.1111/imr.13015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hybel TE, Vase MØ, Maksten EF, Enemark MB, Lauridsen KL, Hamilton-Dutoit S, Andersen C, Møller MB, Sørensen SS, Jespersen B, Kampmann J, d'Amore F, Ludvigsen M. Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder. Acta Oncol 2021;60:1637-42. [PMID: 34474636 DOI: 10.1080/0284186X.2021.1973093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ejaz K, Roback JD, Stowell SR, Sullivan HC. Daratumumab: Beyond Multiple Myeloma. Transfus Med Rev 2021:S0887-7963(21)00023-7. [PMID: 34312046 DOI: 10.1016/j.tmrv.2021.06.002] [Reference Citation Analysis]
11 Joher N, Matignon M, Grimbert P. HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers. Front Immunol 2021;12:688301. [PMID: 34093594 DOI: 10.3389/fimmu.2021.688301] [Reference Citation Analysis]
12 Mayer KA, Doberer K, Eskandary F, Halloran PF, Böhmig GA. New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment. Curr Opin Organ Transplant 2021;26:97-105. [PMID: 33315763 DOI: 10.1097/MOT.0000000000000832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]